Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
MCOLN1	"ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1"	ENSG00000090674	"Mucolipin 1"	Q9GZU1	19	7522626-7534009	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Ion channel"	"Disease mutation, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"	5	"Hofbauer cells: 91.8;Kupffer cells: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"granulocytes: 30.9;monocytes: 28.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031763, CAB032637, HPA069495"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: "	"unprognostic (5.51e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.36e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	18.9	27.5	10.1	10.3	11.9	10.0	10.3	8.2	19.7	7.7	9.6	11.2	7.2	9.6	8.8	9.5	11.2	8.4	11.7	11.7	9.0	9.2	11.5	20.6	17.9	20.6	10.6	10.0	7.8	10.5	9.8	26.0	17.9	13.6	8.8	6.9	9.7	9.2	8.0	14.2	13.9	8.0	9.5	10.4	38.3	8.9	6.5	9.4	7.0	6.2	7.6	5.1	12.5	8.7	1.3	6.2	30.9	28.9	2.8	2.7	4.4	6.4	6.6	3.2	11.0	18.9	6.1	9.3	12.0	9.7	14.6	12.6	5.0	5.7	3.6	14.8	8.1	12.9	3.0	5.4	4.1	4.3	7.0	12.0	3.2	6.5	4.0	16.6	3.6	14.2	8.6	9.7	13.9	2.4	4.6	6.1	8.1	5.9	16.1	8.4	2.1	4.9	3.6	7.2	3.4	14.2	6.9	5.4	7.7	5.5	5.6	8.4	10.3	5.1	9.1	15.2	3.7	5.5	6.4	7.6	7.0	4.0	28.1	8.9	12.4	19.0	2.5	11.2	5.1	10.4	30.9	13.7	29.7	2.3	27.5	2.0	1.1	2.0	1.9	5.6	1.3	1.9	2.0	12.2	2.8	28.9	6.2	2.7	4.4	10.1	11.9	8.2	19.7	9.0	9.2	10.6	10.0	13.6	9.4	3.0	1.6	10.4	6.1	11.8	26.9	2.0	17.8	4.0	1.2	29.6	21.6	10.4	1.7	20.9	4.9	11.9	19.5	46.7	19.9	15.2	17.9	4.5	1.1	12.4	91.8	55.6	16.1	11.1	81.2	10.8	15.3	42.0	20.3	5.4	8.6	23.6	17.7	20.1	14.9	9.2	37.0	6.5	9.2	10.2	11.9	15.2	24.7	10.2	8.6	4.1
MCOLN2	"FLJ36691, TRP-ML2, TRPML2"	ENSG00000153898	"Mucolipin 2"	Q8IZK6	1	84925583-84997113	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Innate immunity, Ion transport, Protein transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 18.9;epididymis: 18.4;lymphoid tissue: 31.9"	"Cell type enhanced"	"Detected in many"	14	"Early spermatids: 34.6;Macrophages: 15.1;monocytes: 53.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 18.9"	"Group enriched"	"Detected in many"	12	"B-cells: 6.6;dendritic cells: 18.9;T-cells: 5.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 14.1;HAP1: 10.1;HDLM-2: 16.8;THP-1: 20.1;U-698: 12.5"	"Region enriched"	"Detected in single"	5	"amygdala: 0.4"	"Low region specificity"	"Detected in all"			HPA019114	Uncertain					NA	NA					"HPA019114: AB_1853645"	"unprognostic (3.02e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.38e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.12e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-2)"	1.3	12.5	0.4	31.9	0.4	2.2	1.1	0.2	0.4	1.7	8.5	0.5	1.6	1.2	1.4	18.4	1.3	2.9	3.8	2.0	0.6	0.4	1.4	0.6	7.5	18.4	0.6	0.0	1.0	1.8	0.0	1.2	2.1	1.5	1.5	14.0	1.6	3.2	0.9	0.6	1.8	7.5	0.5	1.7	9.7	1.7	2.7	0.4	4.1	1.0	2.8	27.5	2.3	1.3	6.6	18.9	0.2	0.8	0.4	5.9	1.4	1.0	1.1	0.1	3.0	0.6	0.2	0.4	0.7	3.8	0.9	1.2	0.0	0.1	14.1	0.4	0.0	1.8	0.1	10.1	1.2	1.1	16.8	7.5	1.4	0.4	0.0	0.8	0.3	1.3	0.2	0.0	0.9	0.8	0.1	0.1	3.7	0.0	0.3	0.2	0.4	0.2	0.1	1.1	0.0	1.9	0.1	2.3	0.0	0.1	0.3	0.7	0.0	0.1	0.2	6.2	0.2	1.8	20.1	0.1	1.0	1.6	0.1	2.6	0.1	0.0	12.5	0.9	0.1	2.4	0.1	0.2	0.0	4.1	0.8	1.3	6.6	3.3	5.9	4.5	1.9	0.5	3.4	0.2	0.4	0.1	18.9	0.2	1.4	0.4	0.4	0.2	0.4	0.6	0.4	0.6	0.0	1.5	0.4	0.0	1.1	9.8	0.5	3.9	0.0	0.5	0.0	2.7	2.3	1.8	0.0	0.1	0.0	0.0	34.6	0.1	6.0	0.0	1.2	0.1	2.1	0.7	0.0	0.0	0.7	0.0	2.4	1.3	0.6	14.2	0.0	15.1	8.5	53.3	4.1	0.0	0.4	5.8	0.0	0.3	0.0	0.0	0.1	0.2	3.7	2.9	0.2	8.2	2.3	0.1
MCOLN3	"FLJ11006, TRP-ML3, TRPML3"	ENSG00000055732	"Mucolipin 3"	Q8TDD5	1	85018082-85048499	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 29.2;pituitary gland: 38.3"	"Group enriched"	"Detected in many"	8	"Intestinal endocrine cells: 109.0;Melanocytes: 143.4"	"Cancer enriched"	"Detected in many"	6	"melanoma: 8.0"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.9"	"Lineage enriched"	"Detected in single"	29	"T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 10.1;HAP1: 10.0;RH-30: 12.2;SK-MEL-30: 21.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 1.7"	"HPA018106, HPA062137"	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Nucleoli, Cytosol"		"HPA018106: AB_1853647, HPA062137: AB_2684695"	"unprognostic (5.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.21e-5)"	"unprognostic (2.25e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.45e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.32e-5)"	"unprognostic (6.36e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.43e-2)"	4.7	29.2	1.5	0.8	0.8	0.0	3.0	0.2	0.4	6.1	2.8	0.9	2.1	3.2	5.4	15.6	0.8	1.1	0.6	5.1	3.4	0.3	4.5	0.2	4.1	0.0	0.5	0.0	2.2	6.5	17.9	38.3	1.8	2.7	0.5	0.5	4.5	8.1	0.4	1.9	2.5	1.9	1.1	0.3	0.9	1.6	0.4	0.3	2.6	1.5	0.9	0.4	0.7	2.8	0.0	0.0	0.0	0.0	0.0	2.9	0.7	6.5	1.5	0.0	0.0	5.3	4.8	1.7	0.1	10.1	2.5	7.0	0.5	1.2	0.0	0.7	0.1	2.3	0.0	10.0	3.2	1.6	2.6	5.9	0.0	0.5	0.0	0.0	0.0	0.0	0.5	1.2	2.1	1.2	2.6	0.0	0.0	0.0	0.0	4.9	0.6	0.0	0.0	0.7	0.0	0.6	0.0	12.2	0.0	0.3	0.0	0.4	0.0	0.3	0.0	21.6	0.8	4.1	5.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.8	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.5	0.8	0.2	0.4	3.4	0.3	0.5	0.0	2.7	0.3	14.9	1.7	0.0	3.6	7.7	0.0	6.9	10.2	0.0	1.2	3.5	0.0	6.4	0.0	1.9	0.3	0.5	1.3	0.0	8.4	0.1	5.1	1.1	0.0	0.0	3.4	0.0	109.0	0.0	0.0	0.0	1.7	0.8	143.4	2.8	0.6	0.0	4.9	7.8	0.0	2.2	0.0	6.5	1.2	0.9	1.6	3.0	2.2	0.0	0.6	0.3
PKD2	"Pc-2, PC2, PKD4, TRPP2"	ENSG00000118762	"Polycystin 2, transient receptor potential cation channel"	Q13563	4	88007668-88077777	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Potassium transport, Transport, Wnt signaling pathway"	"Calcium channel, Ion channel, Potassium channel, Voltage-gated channel"	"Ciliopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Collecting duct cells: 66.3;Peritubular cells: 47.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"basophil: 4.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 36.9;BJ hTERT+: 56.1;fHDF/TERT166: 44.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004544, HPA015794"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Endoplasmic reticulum"		"CAB004544: AB_672377, HPA015794: AB_1855437"	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.51e-1)"	18.4	13.6	8.2	7.7	10.9	5.0	15.1	15.1	10.7	31.4	19.4	15.5	18.5	5.6	42.7	9.8	13.9	25.7	15.3	12.8	9.0	5.2	27.5	7.9	13.4	5.5	12.6	6.4	27.0	9.8	21.9	8.1	12.8	9.2	15.6	7.3	14.1	7.4	22.3	5.4	6.2	9.6	29.3	7.2	5.4	14.8	9.9	12.0	5.5	10.2	3.3	4.9	13.9	21.4	0.5	1.3	4.8	0.8	1.0	1.4	0.4	1.9	10.9	12.3	6.3	28.6	19.1	3.6	36.9	56.1	17.3	17.3	0.5	3.4	1.0	8.1	44.4	6.6	2.4	2.2	5.5	15.2	5.5	1.9	1.7	5.6	1.1	15.9	4.2	3.5	15.8	2.5	13.5	7.3	23.7	7.8	2.0	0.2	2.9	15.0	3.7	2.9	2.0	6.4	1.4	1.8	5.6	7.3	1.5	15.4	4.6	2.5	5.5	6.8	0.3	8.7	13.0	2.6	3.2	12.0	16.4	3.6	4.6	4.9	2.4	0.7	1.2	9.7	0.6	15.0	4.8	0.5	0.9	0.8	0.8	1.4	0.5	0.8	0.6	0.3	0.5	0.9	0.6	0.9	1.0	0.3	1.3	0.4	0.4	8.2	10.9	15.1	10.7	9.0	5.2	12.6	6.4	9.2	12.0	3.0	4.6	1.4	4.2	6.5	14.6	6.3	20.4	16.0	10.3	66.3	9.8	8.7	0.0	10.3	0.3	11.2	0.7	0.0	3.3	3.5	23.9	4.3	1.1	6.8	10.3	25.4	6.4	20.9	4.9	0.7	21.3	8.3	21.9	9.0	2.7	20.1	3.0	5.7	47.7	14.7	1.5	25.8	20.6	0.7	0.9	5.8	2.3	0.7	2.6	2.5
PKD2L1	"PCL, PKD2L, PKDL, TRPP3"	ENSG00000107593	"Polycystin 2 like 1, transient receptor potential cation channel"	Q9P0L9	10	100288154-100330486	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 6.2;lymphoid tissue: 12.0"	"Cell type enhanced"	"Detected in some"	26	"Early spermatids: 15.0;Hofbauer cells: 12.4;Horizontal cells: 57.2;Late spermatids: 15.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.7;intermediate monocyte: 3.0;non-classical monocyte: 2.3"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.6;NB-4: 1.8;PC-3: 2.0;RT4: 1.1;SK-MEL-30: 1.6;U-266/70: 1.0;U-266/84: 2.8;U-937: 1.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			CAB022621	Uncertain					NA	NA					"CAB022621: "	"unprognostic (2.67e-1)"	"unprognostic (3.66e-7)"	"unprognostic (8.07e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.49e-4)"	"unprognostic (3.00e-1)"	"unprognostic (2.05e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	0.3	0.3	0.4	0.6	3.7	1.3	1.4	0.1	6.2	0.1	1.5	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	2.0	0.3	0.5	2.7	4.0	2.3	0.5	4.0	0.2	0.2	0.0	0.2	0.7	1.3	0.4	2.2	1.0	0.3	0.0	0.1	0.1	0.8	0.0	1.5	12.0	0.1	2.3	0.0	0.3	0.1	0.0	2.9	0.4	0.1	0.2	0.3	0.6	3.0	0.0	0.1	0.4	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	1.6	0.0	0.0	0.0	1.8	0.0	1.0	2.0	0.0	0.0	0.0	0.0	1.1	0.4	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.8	0.0	0.0	1.4	0.0	0.0	2.7	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.6	0.0	2.3	0.0	0.0	0.4	0.4	3.7	0.1	6.2	2.0	0.3	0.5	4.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	12.4	57.2	0.0	0.6	6.6	15.9	0.3	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
PKD2L2	TRPP5	ENSG00000078795	"Polycystin 2 like 2, transient receptor potential cation channel"	Q9NZM6	5	137887968-137942747	"Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 7.5;testis: 29.3"	"Group enriched"	"Detected in many"	5	"Early spermatids: 25.9;Spermatocytes: 19.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 5.9;U-266/70: 4.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA041903, HPA043634"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	Cytosol	"HPA041903: AB_2677734, HPA043634: AB_2678591"	"unprognostic (7.53e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.40e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.13e-2)"	"unprognostic (3.00e-2)"	"unprognostic (5.85e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.28e-2)"	"unprognostic (1.22e-1)"	0.5	1.5	2.0	0.6	2.5	2.2	1.2	1.7	1.9	0.5	0.3	0.7	0.7	0.3	0.5	1.0	0.5	0.4	0.6	1.7	1.0	0.8	0.4	0.3	0.4	1.3	1.2	1.3	0.6	1.1	0.0	1.5	0.2	1.8	0.5	0.1	0.2	0.7	0.0	3.3	0.8	0.3	0.0	0.7	1.0	0.6	29.3	0.4	0.0	1.0	0.0	0.2	0.4	0.6	3.9	3.5	7.5	1.7	1.9	1.9	0.8	1.6	1.2	0.2	0.1	0.4	0.5	1.8	0.6	0.0	0.0	0.0	0.1	3.2	2.3	3.5	0.0	0.1	0.7	0.1	0.0	0.1	1.5	1.1	1.3	4.2	0.1	0.0	0.4	1.8	0.1	0.2	0.0	0.0	0.7	0.6	3.3	1.5	5.9	0.8	0.5	1.1	2.4	0.6	0.1	1.0	0.0	0.1	0.0	0.0	2.3	0.8	0.9	1.5	0.2	0.9	0.7	0.4	0.5	0.5	1.0	1.8	0.7	1.0	4.6	3.4	0.4	2.3	0.7	1.8	7.1	1.7	3.0	1.8	1.2	1.0	2.5	1.6	1.4	0.9	3.9	1.9	1.7	7.5	1.9	1.0	3.5	1.1	0.8	2.0	2.5	1.7	1.9	1.0	0.8	1.2	1.3	1.8	0.4	3.0	2.1	0.5	1.6	1.9	2.3	1.5	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.1	25.9	0.8	0.0	0.0	0.0	0.1	1.3	1.3	1.1	0.2	0.2	3.2	0.0	1.3	0.6	4.7	0.6	0.2	3.3	0.0	0.0	0.9	0.1	0.0	0.4	0.2	3.9	0.0	1.2	19.5	2.2	1.0	0.1	0.7	0.0	0.5
TRPA1	ANKTM1	ENSG00000104321	"Transient receptor potential cation channel subfamily A member 1"	O75762	8	72019917-72075617	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"Disease mutation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 20.8;urinary bladder: 20.1;vagina: 12.1"	"Group enriched"	"Detected in some"	10	"Early spermatids: 6.4;Mucus-secreting cells: 5.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	5	"HHSteC: 24.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (2.14e-2)"	"unprognostic (2.50e-2)"	"prognostic favorable (6.57e-4)"	"unprognostic (1.28e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.11e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.16e-4)"	"unprognostic (2.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.90e-1)"	0.3	0.2	0.2	9.1	0.2	0.0	0.2	0.2	0.4	0.4	16.8	0.3	0.0	4.8	0.2	0.3	2.2	0.2	5.7	0.3	0.2	0.2	0.2	0.2	0.3	0.8	0.3	0.0	0.4	0.2	0.0	0.2	0.3	0.1	4.7	7.5	0.0	0.2	0.0	0.2	0.2	20.8	3.8	0.2	0.4	7.9	0.4	0.0	0.6	0.2	0.3	1.4	20.1	12.1	0.5	0.6	0.1	1.1	0.3	2.6	0.2	0.0	2.5	0.7	0.0	0.0	0.1	0.0	0.3	2.3	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.8	0.4	1.4	0.1	0.0	0.5	0.0	24.5	0.0	0.2	1.6	0.0	1.1	0.2	5.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.4	0.0	2.4	0.2	0.0	0.3	0.0	0.1	3.8	1.1	0.0	0.3	0.3	0.0	1.8	0.0	1.7	0.0	0.0	0.0	0.3	0.0	1.1	0.5	0.5	2.6	0.0	0.5	0.0	0.4	0.1	0.3	1.1	0.6	1.0	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0
TRPC1	HTRP-1	ENSG00000144935	"Transient receptor potential cation channel subfamily C member 1"	P48995	3	142724074-142807888	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Bipolar cells: 18.1;Cone photoreceptor cells: 15.7;Horizontal cells: 12.7;Rod photoreceptor cells: 15.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009387, HPA021130"	Supported		Approved	Vesicles		NA	NA			Vesicles		"CAB009387: AB_2240941, HPA021130: AB_1858361"	"unprognostic (1.66e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.37e-5)"	"unprognostic (5.53e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.46e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (2.72e-5)"	"unprognostic (1.44e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.49e-2)"	6.8	8.3	8.5	3.5	13.4	1.2	6.8	23.0	15.9	17.7	8.3	11.4	4.3	2.6	20.4	9.2	6.5	10.1	9.1	15.9	10.0	11.4	6.0	2.0	5.4	3.3	9.4	12.2	24.5	3.0	12.2	14.4	6.1	14.7	12.3	4.9	13.0	3.7	13.6	2.4	6.2	4.7	17.6	11.4	5.0	4.4	8.0	7.9	0.4	8.9	3.9	2.3	9.3	8.9	0.6	0.0	0.0	0.0	0.3	1.3	0.3	3.2	4.6	8.4	1.0	7.6	18.7	3.8	5.1	8.1	6.5	9.6	1.4	0.9	0.0	1.7	5.3	11.4	0.3	2.3	2.4	9.4	0.8	3.4	5.1	1.9	2.2	3.1	0.2	0.0	9.0	2.4	6.0	7.3	11.0	3.7	0.0	0.2	0.0	9.1	2.0	0.3	0.4	4.7	0.0	2.4	0.0	4.0	0.0	4.5	0.1	5.4	4.0	6.3	0.0	1.1	8.0	2.6	0.0	3.4	8.2	1.3	11.0	6.9	3.4	1.4	1.6	6.2	0.1	2.4	0.0	0.0	0.0	0.2	0.0	1.2	0.6	1.3	0.6	0.0	0.3	1.2	1.3	0.0	0.3	0.0	0.0	0.0	0.3	8.5	13.4	23.0	15.9	10.0	11.4	9.4	12.2	14.7	7.9	3.0	0.3	0.0	2.2	2.6	18.1	10.1	0.0	2.7	0.0	5.2	15.7	0.1	0.0	0.2	2.1	2.9	0.0	0.0	0.2	0.2	7.2	0.8	0.0	0.0	0.1	12.7	1.7	4.3	0.0	1.7	7.8	0.0	1.7	0.0	0.0	6.8	0.1	0.0	10.3	0.3	15.0	0.0	9.0	10.3	2.1	1.0	0.2	0.0	0.0	0.2
TRPC3		ENSG00000138741	"Transient receptor potential cation channel subfamily C member 3"	Q13507	4	121879027-121951754	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"brain: 9.3;pituitary gland: 12.0;smooth muscle: 9.4"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 28.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"MAIT T-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.7;HEL: 5.6;Karpas-707: 5.9;U-2 OS: 3.7;U-251 MG: 3.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.12e-3)"	"unprognostic (9.80e-2)"	"unprognostic (4.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.42e-3)"	1.4	0.4	1.8	0.7	9.3	0.3	0.5	5.8	7.4	3.3	0.8	1.7	0.8	0.8	1.6	1.2	0.6	1.1	7.3	0.5	1.8	2.3	0.7	0.5	2.9	0.5	2.3	1.9	0.8	0.2	0.6	12.0	4.2	7.3	1.1	0.8	0.3	0.8	2.5	0.6	0.5	1.2	9.4	1.1	1.0	0.9	1.6	3.6	0.0	0.6	0.0	0.4	3.6	2.4	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.3	1.0	1.5	0.6	0.0	0.0	0.0	0.0	1.0	0.7	0.0	0.9	0.0	0.1	0.0	3.7	5.6	0.1	0.0	0.2	1.5	0.5	0.6	0.0	0.1	0.0	2.5	0.0	0.2	0.0	5.9	1.3	0.0	1.6	0.0	1.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	3.7	0.0	3.3	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	9.3	5.8	7.4	1.8	2.3	2.3	1.9	7.3	3.6	0.0	0.0	0.0	0.0	0.0	2.3	0.7	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	28.1	0.0	0.6	0.1	0.7	0.0	0.0	0.0	0.0	0.0
TRPC4	"HTRP4, TRP4"	ENSG00000133107	"Transient receptor potential cation channel subfamily C member 4"	Q9UBN4	13	37636636-37870425	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 31.0;smooth muscle: 17.2"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 2.4;Smooth muscle cells: 1.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.2;BJ: 16.7;BJ hTERT+ SV40 Large T+: 7.2;fHDF/TERT166: 15.9;U-2197: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (4.52e-4)"	"unprognostic (9.99e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.07e-6)"	"unprognostic (3.73e-3)"	"unprognostic (1.93e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.43e-2)"	1.3	0.8	4.6	1.2	4.0	0.2	0.6	2.1	4.0	5.5	4.1	0.6	6.9	0.8	31.0	2.1	0.4	1.9	4.5	1.9	4.8	2.1	3.0	0.5	4.2	0.3	2.5	0.4	3.8	1.8	0.7	0.5	4.6	3.9	9.5	1.1	0.1	0.5	12.6	0.4	0.5	1.6	17.2	2.5	0.5	3.6	0.8	2.5	0.0	1.1	0.0	0.3	3.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	1.1	2.4	0.0	16.7	2.3	7.2	3.8	0.0	0.2	0.0	0.0	15.9	2.4	0.0	0.1	0.0	3.6	0.0	0.1	0.0	0.3	0.0	2.8	0.0	0.0	1.0	0.0	2.0	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.1	7.6	1.5	4.0	1.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	4.0	2.1	4.0	4.8	2.1	2.5	0.4	3.9	2.5	0.0	0.0	0.0	0.4	0.0	0.5	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TRPC5	PPP1R159	ENSG00000072315	"Transient receptor potential cation channel subfamily C member 5"	Q9UL62	X	111774315-112082776	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"brain: 5.3;liver: 3.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"testis cancer: 0.8;thyroid cancer: 2.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"NTERA-2: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA										"unprognostic (3.29e-2)"		"unprognostic (6.15e-2)"	"unprognostic (7.32e-2)"			"unprognostic (2.60e-3)"		"unprognostic (3.68e-2)"	"unprognostic (5.69e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.78e-2)"		0.0	0.2	0.6	0.0	0.3	0.0	0.0	0.6	5.3	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	2.3	0.4	3.2	0.0	0.0	0.9		0.0	0.2	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRPC6	"FSGS2, TRP6"	ENSG00000137672	"Transient receptor potential cation channel subfamily C member 6"	Q9Y210	11	101451564-101872562	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 35.3;placenta: 20.6"	"Cell type enhanced"	"Detected in some"	16	"Club cells: 19.4;Leydig cells: 5.8;Smooth muscle cells: 9.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"eosinophil: 5.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 5.5"	"Cell line enhanced"	"Detected in some"		"A549: 4.7;ASC diff: 8.8;BJ hTERT+: 4.7;HEL: 4.4;RPTEC TERT1: 21.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"cerebral cortex: 7.1;hippocampal formation: 12.5;midbrain: 9.6"	HPA045098	Approved					NA	NA		140000			"HPA045098: AB_10959600"	"unprognostic (1.45e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.71e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.47e-4)"	"unprognostic (1.99e-3)"	"unprognostic (4.88e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.32e-2)"	6.0	0.5	1.5	0.6	2.4	0.1	9.7	0.8	2.0	7.6	3.9	1.1	7.5	1.1	6.6	7.0	10.8	5.3	3.2	1.1	2.0	1.5	1.6	0.4	35.3	0.9	2.2	3.4	2.2	1.0	1.0	0.6	20.6	2.9	2.3	1.6	0.3	3.3	7.2	0.8	3.0	1.9	3.9	0.7	2.0	1.5	1.0	0.1	0.1	9.6	2.7	1.1	1.6	3.8	0.0	1.0	5.5	0.5	0.0	0.0	0.3	0.0	4.7	0.2	0.0	8.8	2.2	0.0	3.0	4.7	0.7	0.1	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	4.4	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.5	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.3	1.5	2.4	0.8	2.0	2.0	1.5	2.2	3.4	2.9	0.1	0.0	1.6	0.0	1.7	2.1	0.8	0.4	0.0	1.4	19.4	3.5	0.0	0.9	0.0	0.0	0.6	0.8	0.0	0.0	0.2	0.0	1.5	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.8	2.6	1.7	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	9.8	0.0	0.0	3.0	0.3	0.0	0.0	1.0
TRPC7		ENSG00000069018	"Transient receptor potential cation channel subfamily C member 7"	Q9HCX4	5	136213320-136365545	"Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.2;brain: 1.6;intestine: 1.3;kidney: 1.5;pituitary gland: 2.2;testis: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.8;SCLC-21H: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB022592, HPA031126"	Uncertain		Uncertain	"Actin filaments,Focal adhesion sites"		NA	NA			"Focal adhesion sites"	"Actin filaments"	"CAB022592: , HPA031126: AB_10603221"			"unprognostic (1.49e-1)"		"unprognostic (2.08e-1)"					"unprognostic (3.03e-2)"	"unprognostic (2.89e-5)"	"unprognostic (3.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.78e-2)"		0.0	2.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0			1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.0	0.0	0.0		0.0	0.0	0.0	2.2	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.4			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
TRPM1	"CSNB1C, LTRPC1, MLSN1"	ENSG00000134160	"Transient receptor potential cation channel subfamily M member 1"	Q7Z4N2	15	31001061-31161273	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital stationary night blindness, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"retina: 99.0"	"Cell type enriched"	"Detected in some"	5	"Bipolar cells: 705.2"	"Cancer enriched"	"Detected in single"	179	"melanoma: 14.6"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	113	"SK-MEL-30: 16.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014779, HPA071139"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Centriolar satellite"		NA	NA			"Centriolar satellite"	"Golgi apparatus, Plasma membrane"	"HPA014779: AB_2669090, HPA071139: "	"unprognostic (5.28e-2)"	"unprognostic (1.35e-1)"		"unprognostic (9.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.84e-2)"	"unprognostic (6.20e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.63e-2)"	0.1	0.0	0.4	0.0	0.6	0.0	0.1	0.1	0.3	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.3	0.1	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	99.0	0.4	0.0	0.2	10.4	0.0	0.1	1.9	0.0	0.0	2.9	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.4	0.6	0.1	0.3	0.7	0.2	1.6	0.0	0.3	0.1	0.0	0.0	0.0	0.0	3.8	705.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	30.8	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	12.7	0.0	0.0	0.0	2.4	0.0	0.0	150.1	0.0	0.0	10.0	0.0	0.0	0.0	0.6	18.1	0.0	0.0	7.9	3.8	0.9	0.8	0.0	0.0	0.0
TRPM3	"GON-2, KIAA1616, LTRPC3"	ENSG00000083067	"Transient receptor potential cation channel subfamily M member 3"	Q9HCF6	9	70529063-71446904	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 36.6;kidney: 28.0;retina: 105.2"	"Cell type enriched"	"Detected in many"	4	"Muller glia cells: 278.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	16	"NK-cell: 2.1"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 2.1"	"Cell line enriched"	"Detected in some"	4	"HAP1: 19.4"	"Low region specificity"	"Detected in all"							"HPA072650, HPA074393"	Enhanced		Approved	Vesicles		NA	NA			Vesicles		"HPA072650: , HPA074393: "	"unprognostic (3.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-7)"	"unprognostic (3.51e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.50e-2)"	0.9	1.7	6.0	0.7	4.5	1.1	0.8	36.6	5.1	0.8	0.7	9.6	2.1	1.8	2.4	3.0	0.7	1.3	1.3	1.4	9.4	6.0	28.0	0.9	0.8	0.7	8.3	3.5	5.3	1.5	0.7	6.8	0.8	34.8	1.4	0.7	105.2	0.8	5.0	1.1	0.8	0.7	1.0	8.1	1.1	1.6	5.3	5.9	0.0	2.1	0.0	0.6	0.8	0.5	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	1.1	0.1	1.3	3.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	19.4	0.0	0.1	0.0	0.1	0.1	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	2.7	0.2	0.0	0.0	1.2	4.5	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.2	0.0	1.0	0.0	1.3	0.0	0.2	0.0	0.4	0.2	0.0	0.0	3.6	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.5	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	6.0	4.5	36.6	3.8	9.4	6.0	8.3	3.5	34.8	5.9	3.0	4.0	0.0	0.9	0.3	9.5	4.8	2.5	1.4	4.5	15.7	62.8	0.0	5.0	0.0	3.9	1.3	0.0	0.0	0.2	0.0	1.5	0.4	0.0	0.0	0.2	1.6	14.8	0.6	0.0	1.7	5.2	1.1	0.0	0.0	0.0	278.6	0.1	0.0	8.5	25.8	4.7	0.0	1.0	1.5	0.4	0.6	0.2	0.8	0.0	0.3
TRPM4	FLJ20041	ENSG00000130529	"Transient receptor potential cation channel subfamily M member 4"	Q8TD43	19	49157741-49211836	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease mutation, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Enterocytes: 120.1;Mucus-secreting cells: 88.2;Paneth cells: 80.4;Undifferentiated cells: 78.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 85.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 5.4;granulocytes: 4.9;monocytes: 6.8"	"Cell line enhanced"	"Detected in many"		"OE19: 15.6;RT4: 32.4;SK-BR-3: 21.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA041169	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA		6500	"Nucleoplasm, Plasma membrane"		"HPA041169: AB_2677343"	"unprognostic (8.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.86e-2)"	"prognostic favorable (2.88e-7)"	"unprognostic (1.62e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.53e-7)"	"unprognostic (8.46e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.00e-2)"	6.7	3.8	3.5	13.7	3.7	4.3	8.5	3.0	6.8	8.2	25.2	4.5	8.6	20.6	7.9	9.1	7.7	5.4	24.8	9.3	2.7	2.2	14.2	23.6	9.4	3.5	2.6	5.7	2.7	17.4	3.4	3.3	5.0	6.9	20.2	11.4	10.6	16.2	13.2	16.4	16.1	26.8	9.4	2.5	3.4	18.3	4.2	2.2	0.4	10.1	11.5	6.8	9.9	8.6	1.1	5.4	4.9	6.8	1.0	0.7	2.1	6.0	4.5	1.1	5.0	3.8	3.6	3.6	5.1	3.0	1.4	1.9	3.3	9.5	0.2	1.3	3.4	1.9	7.9	0.7	1.5	0.6	0.1	1.6	1.0	1.9	2.0	3.4	0.1	6.6	4.3	7.0	2.6	1.2	1.7	2.4	0.5	2.4	1.2	3.5	9.0	0.4	0.5	0.6	15.6	6.9	2.2	1.0	0.3	2.4	32.4	0.4	1.1	2.1	21.3	1.1	0.4	11.6	2.0	6.1	7.6	4.2	4.2	0.1	2.2	2.2	0.2	4.3	3.9	2.8	2.7	6.8	1.1	0.6	4.0	0.5	0.8	0.5	0.4	5.4	1.1	0.6	0.7	4.9	1.0	1.5	4.9	0.3	2.1	3.5	3.7	3.0	6.8	2.7	2.2	2.6	5.7	6.9	2.2	29.8	1.6	11.7	13.4	11.1	2.1	14.9	22.9	2.7	3.4	14.0	0.0	5.3	16.6	7.6	2.1	9.2	120.1	0.0	16.1	5.7	6.6	47.1	5.7	64.7	16.1	0.0	20.8	15.4	9.7	3.1	6.4	7.9	37.1	14.4	88.2	6.3	25.2	80.4	6.7	3.8	2.4	32.3	9.1	6.6	11.9	10.0	2.9	0.0	78.1	25.3
TRPM5	"LTRPC5, MTR1"	ENSG00000070985	"Transient receptor potential cation channel subfamily M member 5"	Q9NZQ8	11	2404515-2423045	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor, Voltage-gated channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 4.1;intestine: 6.3;pancreas: 4.5;seminal vesicle: 4.0"	"Cell type enhanced"	"Detected in single"	14	"Undifferentiated cells: 1.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MCF7: 2.6;OE19: 3.6;RPMI-8226: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.47e-5)"	"unprognostic (6.81e-4)"	"unprognostic (7.90e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.91e-2)"	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7			6.1	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0		0.0	4.5	0.0	0.5	0.0		0.2	0.5		0.0	4.0	0.0	0.0	6.3	0.0	0.0	0.0	0.5	0.9			3.1		0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.1	0.0	3.6	0.1	0.0	0.0	1.1	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0											0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0
TRPM6	"CHAK2, FLJ22628, HOMG, HSH"	ENSG00000119121	"Transient receptor potential cation channel subfamily M member 6"	Q9BX84	9	74722495-74888094	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease mutation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.1;intestine: 19.5"	"Group enriched"	"Detected in many"	4	"Enterocytes: 28.8;Paneth cells: 10.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 16.1;neutrophil: 6.6"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 16.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.7;HeLa: 4.5;Karpas-707: 2.6;RT4: 7.4;U-266/70: 2.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA						"unprognostic (3.95e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.80e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.72e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.10e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-2)"	2.9	0.0	1.3	0.5	1.2	2.5	1.1	1.3	1.2	0.8	13.3	0.2	1.0	7.2	0.4	0.2	0.6	0.4	1.0	0.5	1.9	1.2	3.1	0.2	1.5	0.2	2.6	0.0	0.4	0.2	3.8	4.9	0.2	1.6	1.7	17.5	0.4	1.1	0.0	1.6	0.8	19.5	0.7	5.0	3.9	0.2	1.7	0.5	1.6	0.3	1.1	2.1	0.5	0.6	0.3	0.3	16.1	0.1	0.5	0.1	0.0	0.1	1.7	0.2	0.2	0.0	0.0	7.7	0.1	0.0	0.0	0.1	2.1	0.2	0.6	0.0	0.1	0.3	0.3	0.5	0.5	0.0	0.1	0.2	0.2	4.5	0.3	0.1	0.1	0.2	0.3	0.2	0.0	0.0	0.1	0.2	0.3	0.0	2.6	0.1	0.9	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.3	0.0	7.4	0.3	0.0	0.0	0.1	0.1	0.4	0.3	0.0	0.0	0.2	1.1	0.2	0.0	2.8	0.0	0.2	0.1	0.1	0.3	16.1	0.1	1.9	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	6.6	0.5	0.1	0.3	0.0	0.0	1.3	1.2	1.3	1.2	1.9	1.2	2.6	0.0	1.6	0.5	0.0	1.7	0.0	1.7	0.1	0.2	0.6	0.0	1.4	2.3	3.5	0.0	0.2	0.0	0.0	2.5	0.7	28.8	0.0	0.0	0.1	0.3	1.1	0.0	0.0	0.0	0.0	3.5	4.9	0.3	0.4	0.0	0.2	0.0	0.0	3.3	0.1	0.0	10.5	0.4	0.0	2.3	0.0	0.3	1.5	2.3	0.9	0.1	0.0	2.6	0.9
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686815	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 91.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Plasma membrane"	"Vesicles, Cytosol"	"HPA035522: , HPA052173: AB_2681749"	"unprognostic (3.14e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.59e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.97e-1)"	13.3	10.8	6.6	14.7	9.0	12.8	12.1	19.5	9.3	11.8	11.7	8.1	9.7	9.9	16.5	10.7	9.4	11.0	8.2	19.1	5.5	4.9	16.0	20.0	10.8	10.6	12.4	5.2	16.6	11.6	91.8	14.6	14.3	10.2	9.7	10.3	28.6	11.5	13.5	10.8	11.7	12.8	12.8	9.8	11.1	10.3	6.9	10.0	14.5	12.6	6.9	12.6	12.9	12.3	7.0	4.7	4.4	3.4	5.7	7.6	2.0	8.5	8.5	7.1	7.9	20.6	15.5	8.7	10.8	15.0	6.9	9.1	11.7	4.7	18.6	5.3	12.4	17.8	14.4	9.5	7.9	9.9	10.3	5.7	14.8	13.1	6.1	18.8	15.3	11.5	14.4	9.4	7.8	14.7	10.1	5.5	11.8	16.7	14.3	12.5	13.4	9.8	7.5	5.4	11.8	5.3	10.8	9.9	9.1	9.6	20.2	5.9	7.5	7.4	11.9	14.5	13.1	7.4	16.7	8.4	11.0	5.2	50.9	12.4	9.7	21.5	17.9	11.9	31.3	10.2	3.8	3.4	3.9	6.6	3.2	7.6	5.6	4.8	4.4	3.7	7.0	4.4	5.2	4.4	5.7	3.2	4.7	4.8	2.0	6.6	9.0	19.5	9.3	5.5	4.9	12.4	5.2	10.2	10.0	17.9	25.3	18.2	14.9	28.0	22.9	21.4	28.1	24.1	7.9	12.2	11.8	18.5	3.3	9.7	25.2	18.5	16.9	23.3	11.1	8.0	17.0	21.2	16.3	35.0	12.7	20.6	17.7	15.4	18.6	17.9	24.5	17.0	18.6	14.4	17.3	9.1	12.8	12.9	19.1	9.6	21.5	12.9	13.7	13.6	19.4	21.1	13.6	17.5	16.3	9.0
TRPM8		ENSG00000144481	"Transient receptor potential cation channel subfamily M member 8"	Q7Z2W7	2	233917398-234019522	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"liver: 16.7;prostate: 44.1"	"Group enriched"	"Detected in some"	7	"Glandular cells: 24.4;Hepatocytes: 42.4"	"Cancer enriched"	"Detected in some"	27	"prostate cancer: 72.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 3.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"GAMG: 4.4;Karpas-707: 7.1;RPTEC TERT1: 10.7;SK-MEL-30: 10.7;WM-115: 6.5"	"Region enhanced"	"Detected in single"		"cerebellum: 0.8"	"Low region specificity"	"Detected in many"									NA	NA						"unprognostic (4.41e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.60e-3)"	"prognostic favorable (7.15e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.88e-3)"	"unprognostic (7.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.36e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.53e-2)"	3.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.7	44.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.9	0.2	3.0	0.3	0.0	0.0	0.7	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	7.1	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.6	0.7	10.7	0.0	0.7	0.4	0.0	0.1	10.7	0.0	0.4	0.7	0.0	0.0	0.1	0.3	0.1	1.6	2.5	0.0	0.9	0.0	6.5	0.5	0.2	0.1	0.3	0.1	0.2	0.2	0.3	0.2	0.0	0.4	0.3	0.3	0.9	3.0	0.1	0.2	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.7	0.9	0.0	0.0	0.0	5.0	0.3	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.0	1.6	0.0	0.0	24.4	0.0	42.4	0.2	0.0	0.0	1.3	0.6	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	1.1	0.4	0.1	0.0	0.0	0.0	2.5
TRPV1	VR1	ENSG00000196689	"Transient receptor potential cation channel subfamily V member 1"	Q8NER1	17	3565444-3609411	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"liver: 11.7"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 15.7;Rod photoreceptor cells: 25.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 13.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA						"unprognostic (3.96e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.83e-2)"	"unprognostic (3.21e-4)"	"unprognostic (9.90e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.43e-3)"	"unprognostic (6.17e-3)"	"unprognostic (6.97e-4)"	"unprognostic (4.25e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.81e-2)"	"unprognostic (5.12e-3)"	1.4	1.2	3.5	0.7	2.9	0.3	1.7	2.7	2.1	2.1	1.4			6.5	2.3	1.5	0.8	2.8	1.1	1.9	3.2	3.6	2.5	11.7	0.7	1.3	4.7		5.1	2.5	1.0	2.0	1.2		1.5	1.7		2.1	1.0	2.8	4.7	5.1	0.9	2.3	1.2	2.2	1.2			1.3		0.8	1.2	1.1	1.1	1.4	1.5	0.8	0.5	2.2	0.3	3.0	5.6	4.5	5.0	4.9	4.7	4.1	1.7	2.4	2.6	2.4	1.4	1.7	1.2	2.3	1.8	1.8	13.2	2.8	0.9	1.9	7.3	6.7	0.7	2.9	5.6	2.2	0.4	5.7	5.6	3.0	3.8	1.5	2.5	0.5	2.9	0.3	2.2	1.5	3.8	2.1	1.0	3.0	0.6	2.7	6.2	2.9	0.9	2.2	2.7	1.9	4.2	2.3	4.4	2.2	3.5	8.3	2.3	1.7	1.1	2.7	4.5	2.2	1.9	1.3	0.5	1.9	2.4	2.4	0.9	0.8	1.5	0.7	0.2	0.9	0.4	0.6	0.2	0.1	1.1	0.8	2.2	1.5	0.5	0.3	1.4	0.2	0.3											0.0	1.6	0.0	0.4	0.0	8.6	0.2	2.5	4.0	2.3	5.2	15.7	1.0	0.0	0.4	1.8	0.0	2.6	0.0	0.6	0.3	0.4	0.6	0.0	6.4	0.7	6.4	1.2	2.5	0.6	0.2	4.4	1.2	0.0	0.0	1.5	2.8	0.4	0.0	3.5	1.4	25.1	0.0	0.1	0.7	0.7	0.0	0.7	0.0	2.2	0.3
TRPV4	"CMT2C, OTRPC4, TRP12, VR-OAC, VRL-2, VROAC"	ENSG00000111199	"Transient receptor potential cation channel subfamily V member 4"	Q9HBA0	12	109783085-109833401	"Disease related genes, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Charcot-Marie-Tooth disease, Disease mutation, Dwarfism, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 32.6"	"Cell type enhanced"	"Detected in many"	6	"Cholangiocytes: 15.3;Cytotrophoblasts: 16.0;Syncytiotrophoblasts: 17.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	11	"pons and medulla: 15.0"	"Cell type enriched"	"Detected in single"	7	"classical monocyte: 3.0"	"Lineage enriched"	"Detected in single"	7	"monocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 9.0;BJ hTERT+: 9.3;EFO-21: 8.2;HaCaT: 14.8;HUVEC TERT2: 8.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA007150	Uncertain					NA	NA					"HPA007150: AB_1080393"	"unprognostic (2.98e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.20e-3)"	"unprognostic (6.25e-3)"	"unprognostic (1.09e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.03e-1)"	"unprognostic (9.02e-2)"	"prognostic unfavorable (8.10e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.68e-1)"	"prognostic favorable (4.12e-5)"	"unprognostic (1.20e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.73e-2)"	1.3	0.9	0.3	0.9	0.4	0.1	3.3	0.2	0.6	2.3	0.4	3.2	0.0	0.6	0.8	3.7	9.5	5.6	5.2	1.6	1.3	0.2	11.6	7.8	2.6	1.8	0.2	0.0	0.6	7.1	0.1	4.3	11.1	15.0	6.2	0.3	12.6	32.6	1.4	0.2	6.5	0.3	0.9	0.3	3.5	0.9	0.7	0.1	0.2	0.9	2.6	8.7	2.6	1.7	0.0	0.4	0.0	3.0	0.0	0.0	0.4	2.6	0.1	0.0	0.0	1.9	1.9	9.0	4.3	9.3	1.3	0.5	0.0	6.4	0.0	8.2	5.5	0.0	14.8	1.1	0.0	0.3	0.0	2.1	0.0	0.0	3.6	0.7	0.0	0.0	3.3	2.0	3.3	0.0	0.5	8.4	0.0	0.8	0.0	0.4	5.4	0.0	0.0	1.7	0.0	0.3	0.0	0.5	0.0	0.0	5.2	0.0	0.0	0.3	0.6	2.6	4.1	1.2	0.4	5.1	0.0	3.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.9	0.0	3.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.2	0.6	1.3	0.2	0.2	0.0	15.0	0.1	0.0	0.0	1.3	8.2	3.0	0.0	1.1	15.3	5.3	6.8	10.4	0.0	16.0	3.3	2.2	0.2	0.5	0.0	0.0	8.4	4.3	0.7	3.7	0.0	6.4	3.6	0.0	0.0	0.6	10.7	0.0	0.9	1.6	6.8	1.0	0.0	0.0	1.5	0.0	0.0	11.1	0.0	0.0	0.8	0.2	1.3	3.3	17.6	0.0	0.0	2.0
TRPV5	"CaT2, ECAC1"	ENSG00000127412	"Transient receptor potential cation channel subfamily V member 5"	Q9NQA5	7	142908101-142933808	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"kidney: 26.0"	"Cell type enriched"	"Detected in single"	8	"Collecting duct cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.2"	"Cell line enhanced"	"Detected in single"		"RT4: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA063175	Uncertain					NA	NA					"HPA063175: AB_2684954"	"unprognostic (7.44e-2)"	"unprognostic (3.93e-2)"		"unprognostic (1.22e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"		"unprognostic (3.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.95e-2)"	"unprognostic (7.73e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.58e-1)"	"unprognostic (7.76e-3)"	0.1	0.0	0.8	0.4	0.7	0.5	0.5	0.1	0.8	0.1	0.1	0.1	0.1	0.7	0.1	0.3	0.1	0.1	0.1	0.1	1.1	0.7	26.0	0.1	0.1	0.2	1.6	0.4	0.1	0.3	0.0	0.1	0.1	0.7	0.1	0.0	0.1	0.3	0.1	0.2	0.1	0.1	0.1	3.5	0.2	0.0	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.2	0.3	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.1	0.5	1.1	0.7	1.6	0.4	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRPV6	"CaT1, ECAC2"	ENSG00000165125	"Transient receptor potential cation channel subfamily V member 6"	Q9H1D0	7	142871203-142885762	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"pancreas: 26.1;placenta: 65.1;salivary gland: 34.2"	"Cell type enhanced"	"Detected in many"	13	"Cholangiocytes: 25.5;Collecting duct cells: 26.2;Ductal cells: 63.7;Early spermatids: 26.4;Late spermatids: 28.8"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.7;HaCaT: 10.5;RT4: 18.7;SK-BR-3: 13.8;T-47d: 30.8"	"Low region specificity"	"Detected in some"							HPA062864	Approved					NA	NA					"HPA062864: AB_2684885"	"unprognostic (9.85e-2)"	"unprognostic (1.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.49e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.53e-2)"	0.3	0.0	0.3	0.3	0.3	0.0	2.1	0.3	0.3	0.4	1.2	0.3	0.3	4.1	0.3	0.4	1.7	0.1	4.1	0.3	0.3	0.2	2.5	0.6	0.8	0.3	0.8	0.3	0.3	26.1	0.0	0.4	65.1	0.4	12.6	0.0	0.4	34.2	0.7	0.3	3.7	1.0	0.5	2.0	0.3	2.4	0.7	0.3	0.3	0.7	0.6	1.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	1.1	0.0	0.0	13.8	0.3	0.6	30.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.2	0.8	0.3	0.4	0.3	3.0	0.0	0.0	0.9	0.5	0.4	1.6	25.5	1.4	2.3	26.2	0.0	13.3	0.0	63.7	26.4	0.0	0.0	0.0	2.8	0.6	0.4	14.3	0.0	0.0	1.4	3.2	0.0	0.0	0.0	28.8	0.9	0.0	0.0	3.6	0.0	0.8	13.2	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	1.6	5.0	0.0	0.0	3.1